Addressing the oxamniquine in vitro-in vivo paradox to facilitate a new generation of anti-schistosome treatments

por Toth, Katalin, Alwan, Sevan, Khan, Susan, McHardy, Stanton F., LoVerde, Philip T., Cameron, Michael D.
Publicado 2023

Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis

por Alwan, Sevan N., Taylor, Alexander B., Rhodes, Jayce, Tidwell, Michael, McHardy, Stanton F., LoVerde, Philip T.
Publicado 2023

Rational approach to drug discovery for human schistosomiasis

por LoVerde, Philip T., Alwan, Sevan N., Taylor, Alexander B., Rhodes, Jayce, Chevalier, Frédéric D., Anderson, Timothy JC., McHardy, Stanton F.
Publicado 2021

Corrigendum to “Rational approach to drug discovery for human schistosomiasis” [Int. J. Parasitol. Drugs Drug Resist. 16 (2021) 140–147]

por LoVerde, Philip T., Alwan, Sevan N., Taylor, Alexander B., Rhodes, Jayce, Chevalier, Frédéric D., Anderson, Timothy Jc, McHardy, Stanton F.
Publicado 2022

Genotyping of Cytomegalovirus from Symptomatic Infected Neonates in Iraq

por Alwan, Sevan N., Shamran, Haidar A., Ghaib, Avan H., Kadhim, Haider S., Al-Mayah, Qasim S., AL-Saffar, Atheer J., Bayati, Ali H., Arif, Hala S., Fu, Jianmin, Wickes, Brian L.
Publicado 2019

Schistosome Sulfotransferases: Mode of Action, Expression and Localization

por Guzman, Meghan A., Rugel, Anastasia, Alwan, Sevan N., Tarpley, Reid, Taylor, Alexander B., Chevalier, Frédéric D., Wendt, George R., Collins, James J., Anderson, Timothy J. C., McHardy, Stanton F., LoVerde, Philip T.
Publicado 2022

An iterative process produces oxamniquine derivatives that kill the major species of schistosomes infecting humans

por Guzman, Meghan A., Rugel, Anastasia R., Tarpley, Reid S., Alwan, Sevan N., Chevalier, Frédéric D., Kovalskyy, Dmytro P., Cao, Xiaohang, Holloway, Stephen P., Anderson, Timothy J. C., Taylor, Alexander B., McHardy, Stanton F., LoVerde, Philip T.
Publicado 2020